AI-guided DNA switches for precise, safe, and adaptive cancer therapy
Project Overview
OncoSwitch is developing an AI-guided platform that designs DNA switches capable of activating therapeutic genes only in cancer cells while remaining silent in healthy tissue.
Our system integrates high-throughput MPRA data with machine learning to iteratively design, test, and optimize regulatory sequences.
Within 18 months, the platform aims to deliver 3–5 patentable DNA switches and launch collaborations with biotech and pharma partners.
Our Core Team
Founder & CEO
Malika Gallyamova
- MSc Al & Computer Science, University of Birmingham
- Expert in networking and communications
- Experience managing teams and complex processes
Scientific CТО
Vitalii Volkov
- MSc Al & Computer Science, University of Birmingham
- Graduate of Pirogov Russian National Research Medical University
- Senior Bioinformatician at Genomed
Get in Touch with Us
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
